Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$7500
Buy Report View Sample

Published: October 25, 2023 Report Code: GDME626MM-ST

Select Item

Diabetes Assays Market Report Overview

The diabetes assays market size was $564.6 million in 2023. Factors such as an increased prevalence of diabetes in North America will drive market growth at a CAGR of more than 1% from 2023 to 2033.

Diabetes assays diagnose diabetes and assess its risk, such as pre-diabetes, through analysis of blood.

Diabetes Assays Market Outlook 2023-2033 ($ Million)

Diabetes Assays Market Outlook 2023-2033 ($ Million)

Buy the Full Report for More Insights on the Diabetes Assays Market Forecast, Download a Free Sample Report

The diabetes assays market research report identifies quantitative market trends within the in vitro diagnostics therapeutic area. The report offers regional quantitative and qualitative data highlighting the sales in major markets. The model also covers in detail the effects of COVID-19 on the diabetes assays market for 2020 and beyond. Furthermore, the report provides diabetes assays market share by company that will help in identifying untapped market opportunities.

Market Size (2023) $564.6 Million
CAGR (2023-2033) >1%
Historic Period 2015-2023
Forecast Period 2023-2033
Key Segments ·       C-Peptide Assay

·       Fasting Glucose Assay

·       Glycated Hemoglobin (HbA1c) Lab Assay

·       Glycated Hemoglobin (HbA1c) Point of care (POC) Assay

·       Insulin Assay
Key Regions ·       Asia-Pacific

·       Europe

·       Middle East and Africa

·       North America

·       South America
Key Companies ·       Siemens Healthineers AG

·       Abbott Laboratories

·       ALPCO Diagnostics

·       Danaher Corp

·       Bio-Rad Laboratories Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Diabetes Assays Market by Segments

The key segments of the diabetes assays market are the C-peptide assay, fasting glucose assay, glycated hemoglobin (HbA1c) lab assay, glycated hemoglobin (HbA1c) point of care (POC) assay, and insulin assay. In 2023, glycated hemoglobin (HbA1c) point of care (POC) assay led the market.

Glycated hemoglobin (HbA1c) point of care (POC) assays use a drop of capillary whole blood, collected via the finger-prick procedure, to provide immediate results at the time of patient consultation, to diagnose diabetes.

Diabetes Assays Market Analysis by Segments, 2023 (%)

Diabetes Assays Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Insights into the Glycated Hemoglobin (HbA1c) Point of Care (POC) Assay Market, Download a Free Sample Report

Glycated Hemoglobin (HbA1c) lab assays are used to measure mean blood glucose levels over the preceding 2-3 months, to screen for and diagnose diabetes (or pre-diabetes) as well as to monitor existing diabetes patients.

Buy the Full Report for More Segment-Wise Insights on the Diabetes Assays Market, Download a Free Sample Report

Diabetes Assays Market Segmentation by Regions

The key regions in the diabetes assays market are North America, Europe, Asia Pacific, South America, and the Middle East and Africa. In 2023, the North American diabetes assays market was the leading regional segment.

Increased incidence and prevalence of diabetes will drive the North American diabetes assays market growth. The rising awareness of diabetes care, the growing prevalence of obesity, and technological advancements will also support the regional market growth.

In the US diabetes assays market, glycated hemoglobin (HbA1c) point-of-care (POC) assays comprised the largest segment due to a high average selling price (ASP) compared to the other device segments.

Diabetes Assays Market Analysis by Regions, 2023 (%)

Diabetes Assays Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights into the Diabetes Assays Market, Download a Free Sample Report

Diabetes Assays Market – Competitive Landscape

In 2023, Siemens diabetes assays market share was the highest

A few of the major players in the diabetes assays market are:

  • Siemens Healthineers AG
  • Abbott Laboratories
  • ALPCO Diagnostics
  • Danaher Corp
  • Bio-Rad Laboratories Inc

The key strategy that major companies can follow is to invest in training and education schemes to promote diabetes disease awareness in countries with the potential to implement more comprehensive screening strategies. Companies can also familiarize physicians with their brand or type of devices.

Companies may wish to partner with government organizations, third-party distributors, and physician societies to try and ensure that their device is adopted by national screening programs. This has the potential to increase the volume of sales.

Diabetes Assays Market Analysis by Companies, 2023 (%)

Diabetes Assays Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Diabetes Assays Market, Download a Free Sample Report

Diabetes Assays Market Dynamics

  • Trends: The International Diabetes Federation recommends screening for type II diabetes for individuals with high-risk factors. This includes obese patients who are either older than 45 years or have additional risk factors such as a family history of diabetes or polycystic ovary syndrome. Guidelines also recommend that if test results are normal, repeat testing should be performed periodically. Patients with abnormal results should also be referred for counseling interventions focused on physical activity and a healthy diet.
  • Future Outlook: GlobalData expects the market for diabetes assays to grow in Europe, North America, and APAC during the forecast period. The increasing prevalence of diabetes in North America and the growing diabetes incidence rates in Europe and APAC are the primary reasons for strong growth in the regional market. Additionally, many APAC countries have large patient populations and improving healthcare systems, which is expected to intensify growth in these markets.

Purchase the Complete Report for Additional Insights on the Diabetes Assays Market Dynamics, Get a Free Sample Report Here

Segments Covered in this Report

Diabetes Assays Segment Outlook ($ Million, 2015-2033)

  • C-Peptide Assay
  • Fasting Glucose Assay
  • Glycated Hemoglobin (HbA1c) Lab Assay
  • Glycated Hemoglobin (HbA1c) Point of care (POC) Assay
  • Insulin Assay

Diabetes Assays Regional Outlook ($ Million, 2015-2033)

  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South America

Key Inclusions of the market model are:

The diabetes assays market research report includes an insightful review of the key industry trends.

  • The diabetes assays market report offers an annualized market revenue by segment and market outlooks from 2015-2033.
  • The report also includes market-level data on units, average selling prices, and market values.

Regional, Country, and Global Diabetes Assays Market Insights:

  • The diabetes assays market share report offers qualitative insights on global and regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • Diabetes assays market SWOT analysis.
  • The report provides trends and diabetes assays for market competitive dynamics.

Buy the Full Report for More Insights on the Diabetes Assays Market Share, Download a Free Sample Report

Learn about consumer behavior through the detailed overview of segments and the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. These syndicated models include demand and supply-side primary sources including Key opinion leaders. In addition, determine market trends through real-world data sources including databases of government procedures and hospital purchasing.

Companies Covered: Abbott Laboratories, ALPCO Diagnostics, Bio-Rad Laboratories Inc, DiaSorin SpA, Quidelortho Corp, Sinocare Inc, Danaher Corp, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Tosoh Corp, EKF Diagnostics Holdings Plc, and others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile

Scope

  • Extensive coverage of the diabetes assays market under development.

  • An exhaustive list of major pipeline products and their details, including product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of the diabetes assays market and lists all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Understand the COVID-19 impact on diabetes assays.

  • Design your licensing strategies through a review of products, technologies, and companies with the most robust pipeline.

  • Develop business strategies by understanding the trends shaping and driving diabetes assays.

  • Understand the trends, innovative product launches, technologies, segments, and companies that will impact the market in the future.

  • Formulate effective sales and marketing strategies with a detailed evaluation of diabetes assays market share by company. Identify strong competitors and create winning strategies to stand out in the global diabetes assays market.

  • Track regional diabetes assays market sales as well as country-specific transactions from 2015-2033.

  • Organize your sales and marketing efforts by identifying the global diabetes assays market segments that present maximum opportunities. Such details will help to make investments and strategic partnerships.

Frequently asked questions

Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 standard reports
Currency USD
$7,500

Can be used by individual purchaser only

Most Popular
$15,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Diabetes Assays reports
Medical Devices
New
Venous Stents Market Size by Segments, Share, Regulatory, Reimbursement, Procedures…
$7,500 | April 2024
Medical Devices
Germany Surgical Stapling Devices Market Size (Value, Volume, ASP) by…
$500 | July 2020
Medical Devices
India Surgical Energy Instruments Market Size (Value, Volume, ASP) by…
$500 | July 2020
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 in real time.

  • Access a live Diabetes Assays Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more